About Source Bioscience PLC
Source BioScience plc is a provider of laboratory services and products to the healthcare and clinical, life and applied sciences and biopharmaceutical industries. The Company operates through two segments: Laboratory Services and Products. The Company's Laboratory Services segment consists of the laboratory and analytical testing activities of the Group including diagnostic testing for cancer and infectious disease; deoxyribonucleic acid (DNA) sequencing and contract research activities; stability and cryostorage in addition to analytical services, and stability testing. The Company's Products segment consists of portfolio of Clinical Products, including serology products for blood and tissue banking and liquid-based cytology products for cervical cancer screening, in addition to the portfolio of Life Science Research Reagents, including complementary DNA (cDNA) clones and other biomolecular tools, and controlled environment storage equipment and related servicing and validation.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: LON
- Symbol: SBS
- Previous Close: $0.22
- 50 Day Moving Average: $17.81
- 200 Day Moving Average: $16.38
- 52-Week Range: GBX 14 - GBX 19
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Market Cap: $N/A
Consensus Ratings for Source Bioscience PLC (LON:SBS) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Source Bioscience PLC (LON:SBS)
(Data available from 2/22/2015 forward)
|1/29/2016||N+1 Singer||Reiterated Rating||corporate|
Earnings History for Source Bioscience PLC (LON:SBS)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Source Bioscience PLC (LON:SBS)
Current Year EPS Consensus Estimate: $1.00 EPS
Dividend History for Source Bioscience PLC (LON:SBS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Source Bioscience PLC (LON:SBS)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/8/2015||Ash,Dr Nick||Insider||Sell||1,454,243||GBX 17||£247,221.31|
Latest Headlines for Source Bioscience PLC (LON:SBS)
What is Source Bioscience PLC's stock symbol?
Source Bioscience PLC trades on the London Stock Exchange (LON) under the ticker symbol "SBS."
When will Source Bioscience PLC announce their earnings?
Source Bioscience PLC is scheduled to release their next quarterly earnings announcement on Tuesday, March, 22nd 2016.
How do I buy Source Bioscience PLC stock?
Shares of Source Bioscience PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Source Bioscience PLC stock cost?
One share of Source Bioscience PLC stock can currently be purchased for approximately GBX 17.50.